Global Buserelin Acetate Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032416093

Publication Date:

April 8, 2024

Pages:

127

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Buserelin Acetate market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Buserelin Acetate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Buserelin Acetate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Buserelin Acetate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Buserelin Acetate total production and demand, 2019-2030, (Tons)
Global Buserelin Acetate total production value, 2019-2030, (USD Million)
Global Buserelin Acetate production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Buserelin Acetate consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Buserelin Acetate domestic production, consumption, key domestic manufacturers and share
Global Buserelin Acetate production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Buserelin Acetate production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Buserelin Acetate production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).
This reports profiles key players in the global Buserelin Acetate market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include EUROAPI, Bachem, BCNpeptides, Suanfarma, ILS Inc., Piramal Enterprises Limited, Tofigh Daru, Chinese Peptide Company and Shenzhen JYMed Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Buserelin Acetate market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Buserelin Acetate 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Buserelin Acetate 麻豆原创, Segmentation by Type
Purity 98%
Purity 99%
Global Buserelin Acetate 麻豆原创, Segmentation by Application
Oncology Drugs
Assisted Reproduction
Veterinary Medicine
Companies Profiled:
EUROAPI
Bachem
BCNpeptides
Suanfarma
ILS Inc.
Piramal Enterprises Limited
Tofigh Daru
Chinese Peptide Company
Shenzhen JYMed Technology
Suzhou Motif
Key Questions Answered
1. How big is the global Buserelin Acetate market?
2. What is the demand of the global Buserelin Acetate market?
3. What is the year over year growth of the global Buserelin Acetate market?
4. What is the production and production value of the global Buserelin Acetate market?
5. Who are the key producers in the global Buserelin Acetate market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Buserelin Acetate Introduction
1.2 World Buserelin Acetate Supply & Forecast
1.2.1 World Buserelin Acetate Production Value (2019 & 2023 & 2030)
1.2.2 World Buserelin Acetate Production (2019-2030)
1.2.3 World Buserelin Acetate Pricing Trends (2019-2030)
1.3 World Buserelin Acetate Production by Region (Based on Production Site)
1.3.1 World Buserelin Acetate Production Value by Region (2019-2030)
1.3.2 World Buserelin Acetate Production by Region (2019-2030)
1.3.3 World Buserelin Acetate Average Price by Region (2019-2030)
1.3.4 North America Buserelin Acetate Production (2019-2030)
1.3.5 Europe Buserelin Acetate Production (2019-2030)
1.3.6 China Buserelin Acetate Production (2019-2030)
1.3.7 Japan Buserelin Acetate Production (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 Buserelin Acetate 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 Buserelin Acetate Major 麻豆原创 Trends
2 Demand Summary
2.1 World Buserelin Acetate Demand (2019-2030)
2.2 World Buserelin Acetate Consumption by Region
2.2.1 World Buserelin Acetate Consumption by Region (2019-2024)
2.2.2 World Buserelin Acetate Consumption Forecast by Region (2025-2030)
2.3 United States Buserelin Acetate Consumption (2019-2030)
2.4 China Buserelin Acetate Consumption (2019-2030)
2.5 Europe Buserelin Acetate Consumption (2019-2030)
2.6 Japan Buserelin Acetate Consumption (2019-2030)
2.7 South Korea Buserelin Acetate Consumption (2019-2030)
2.8 ASEAN Buserelin Acetate Consumption (2019-2030)
2.9 India Buserelin Acetate Consumption (2019-2030)
3 World Buserelin Acetate Manufacturers Competitive Analysis
3.1 World Buserelin Acetate Production Value by Manufacturer (2019-2024)
3.2 World Buserelin Acetate Production by Manufacturer (2019-2024)
3.3 World Buserelin Acetate Average Price by Manufacturer (2019-2024)
3.4 Buserelin Acetate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Buserelin Acetate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Buserelin Acetate in 2023
3.5.3 Global Concentration Ratios (CR8) for Buserelin Acetate in 2023
3.6 Buserelin Acetate 麻豆原创: Overall Company Footprint Analysis
3.6.1 Buserelin Acetate 麻豆原创: Region Footprint
3.6.2 Buserelin Acetate 麻豆原创: Company Product Type Footprint
3.6.3 Buserelin Acetate 麻豆原创: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of 麻豆原创 Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Buserelin Acetate Production Value Comparison
4.1.1 United States VS China: Buserelin Acetate Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Buserelin Acetate Production Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Buserelin Acetate Production Comparison
4.2.1 United States VS China: Buserelin Acetate Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Buserelin Acetate Production 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Buserelin Acetate Consumption Comparison
4.3.1 United States VS China: Buserelin Acetate Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Buserelin Acetate Consumption 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Buserelin Acetate Manufacturers and 麻豆原创 Share, 2019-2024
4.4.1 United States Based Buserelin Acetate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Buserelin Acetate Production Value (2019-2024)
4.4.3 United States Based Manufacturers Buserelin Acetate Production (2019-2024)
4.5 China Based Buserelin Acetate Manufacturers and 麻豆原创 Share
4.5.1 China Based Buserelin Acetate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Buserelin Acetate Production Value (2019-2024)
4.5.3 China Based Manufacturers Buserelin Acetate Production (2019-2024)
4.6 Rest of World Based Buserelin Acetate Manufacturers and 麻豆原创 Share, 2019-2024
4.6.1 Rest of World Based Buserelin Acetate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Buserelin Acetate Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Buserelin Acetate Production (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World Buserelin Acetate 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Purity 98%
5.2.2 Purity 99%
5.3 麻豆原创 Segment by Type
5.3.1 World Buserelin Acetate Production by Type (2019-2030)
5.3.2 World Buserelin Acetate Production Value by Type (2019-2030)
5.3.3 World Buserelin Acetate Average Price by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World Buserelin Acetate 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Oncology Drugs
6.2.2 Assisted Reproduction
6.2.3 Veterinary Medicine
6.3 麻豆原创 Segment by Application
6.3.1 World Buserelin Acetate Production by Application (2019-2030)
6.3.2 World Buserelin Acetate Production Value by Application (2019-2030)
6.3.3 World Buserelin Acetate Average Price by Application (2019-2030)
7 Company Profiles
7.1 EUROAPI
7.1.1 EUROAPI Details
7.1.2 EUROAPI Major Business
7.1.3 EUROAPI Buserelin Acetate Product and Services
7.1.4 EUROAPI Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 EUROAPI Recent Developments/Updates
7.1.6 EUROAPI Competitive Strengths & Weaknesses
7.2 Bachem
7.2.1 Bachem Details
7.2.2 Bachem Major Business
7.2.3 Bachem Buserelin Acetate Product and Services
7.2.4 Bachem Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 Bachem Recent Developments/Updates
7.2.6 Bachem Competitive Strengths & Weaknesses
7.3 BCNpeptides
7.3.1 BCNpeptides Details
7.3.2 BCNpeptides Major Business
7.3.3 BCNpeptides Buserelin Acetate Product and Services
7.3.4 BCNpeptides Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 BCNpeptides Recent Developments/Updates
7.3.6 BCNpeptides Competitive Strengths & Weaknesses
7.4 Suanfarma
7.4.1 Suanfarma Details
7.4.2 Suanfarma Major Business
7.4.3 Suanfarma Buserelin Acetate Product and Services
7.4.4 Suanfarma Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Suanfarma Recent Developments/Updates
7.4.6 Suanfarma Competitive Strengths & Weaknesses
7.5 ILS Inc.
7.5.1 ILS Inc. Details
7.5.2 ILS Inc. Major Business
7.5.3 ILS Inc. Buserelin Acetate Product and Services
7.5.4 ILS Inc. Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 ILS Inc. Recent Developments/Updates
7.5.6 ILS Inc. Competitive Strengths & Weaknesses
7.6 Piramal Enterprises Limited
7.6.1 Piramal Enterprises Limited Details
7.6.2 Piramal Enterprises Limited Major Business
7.6.3 Piramal Enterprises Limited Buserelin Acetate Product and Services
7.6.4 Piramal Enterprises Limited Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 Piramal Enterprises Limited Recent Developments/Updates
7.6.6 Piramal Enterprises Limited Competitive Strengths & Weaknesses
7.7 Tofigh Daru
7.7.1 Tofigh Daru Details
7.7.2 Tofigh Daru Major Business
7.7.3 Tofigh Daru Buserelin Acetate Product and Services
7.7.4 Tofigh Daru Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Tofigh Daru Recent Developments/Updates
7.7.6 Tofigh Daru Competitive Strengths & Weaknesses
7.8 Chinese Peptide Company
7.8.1 Chinese Peptide Company Details
7.8.2 Chinese Peptide Company Major Business
7.8.3 Chinese Peptide Company Buserelin Acetate Product and Services
7.8.4 Chinese Peptide Company Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 Chinese Peptide Company Recent Developments/Updates
7.8.6 Chinese Peptide Company Competitive Strengths & Weaknesses
7.9 Shenzhen JYMed Technology
7.9.1 Shenzhen JYMed Technology Details
7.9.2 Shenzhen JYMed Technology Major Business
7.9.3 Shenzhen JYMed Technology Buserelin Acetate Product and Services
7.9.4 Shenzhen JYMed Technology Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Shenzhen JYMed Technology Recent Developments/Updates
7.9.6 Shenzhen JYMed Technology Competitive Strengths & Weaknesses
7.10 Suzhou Motif
7.10.1 Suzhou Motif Details
7.10.2 Suzhou Motif Major Business
7.10.3 Suzhou Motif Buserelin Acetate Product and Services
7.10.4 Suzhou Motif Buserelin Acetate Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 Suzhou Motif Recent Developments/Updates
7.10.6 Suzhou Motif Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Buserelin Acetate Industry Chain
8.2 Buserelin Acetate Upstream Analysis
8.2.1 Buserelin Acetate Core Raw Materials
8.2.2 Main Manufacturers of Buserelin Acetate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Buserelin Acetate Production Mode
8.6 Buserelin Acetate Procurement Model
8.7 Buserelin Acetate Industry Sales Model and Sales Channels
8.7.1 Buserelin Acetate Sales Model
8.7.2 Buserelin Acetate Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

EUROAPI
Bachem
BCNpeptides
Suanfarma
ILS Inc.
Piramal Enterprises Limited
Tofigh Daru
Chinese Peptide Company
Shenzhen JYMed Technology
Suzhou Motif

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.